Latest Ciprofloxacin Stories
WHIPPANY, N.J., Nov. 24, 2014 /PRNewswire/ -- The U.S.
This innovative combination of drugs could become the treatment of choice in those cases BARCELONA, Spain, September 29, 2014 /PRNewswire/ -- Laboratorios SALVAT
PINE BROOK, N.J., Sept. 22, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc.
LifeScienceIndustryResearch.com adds Latest Report on “Market Research Report on Global and Chinese Ciprofloxacin HCl Industry, 2009-2019” to its store.
SAN DIEGO, July 8, 2014 /PRNewswire/ -- Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and
The Centers for Disease Control and Prevention (CDC) is one of those government agencies that is almost universally regarded as entirely competent and worthy have having the complete trust of the American public. This stellar reputation may, in fact, be wholly unwarranted.
A Group of 50 Adverse Drug Reaction Victims Rally in Washington, DC Before Meeting with Members of Congress; Thousands Connect Via Online Support Groups Emerging Worldwide WASHINGTON,
SAN DIEGO, May 8, 2014 /PRNewswire/ -- Otonomy, Inc., a biopharmaceutical company developing and commercializing innovative therapeutics for diseases and disorders of the inner and middle
Drug Allegedly Linked to Serious Muscle Problems and Nerve Damage Dallas, TX (PRWEB) February 20, 2014 The national law firm of
Over 400 subjects participating in phase 3 studies PINE BROOK, N.J., Feb. 5, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc.